Garrett Winslow
General Counsel at GALECTO, INC.
Net worth: 2 432 $ as of 2024-05-30
Garrett Winslow active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GALECTO, INC. | General Counsel | 2021-05-10 | - |
| Corporate Secretary | 2021-05-10 | - |
Career history of Garrett Winslow
Former positions of Garrett Winslow
| Companies | Position | Start | End |
|---|---|---|---|
| SPRING BANK PHARMACEUTICALS, INC. | General Counsel | 2017-01-04 | 2020-11-19 |
| Corporate Secretary | 2017-01-04 | - | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Training of Garrett Winslow
| Boston University School of Law | Graduate Degree |
| Suffolk University Law School | Graduate Degree |
| University of Washington | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Secretary | 2 |
| General Counsel | 2 |
| Graduate Degree | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GALECTO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
- Stock Market
- Insiders
- Garrett Winslow
- Experience
